Journal of Genetic Counseling

, Volume 23, Issue 2, pp 221–228 | Cite as

Acceptability of Telemedicine and Other Cancer Genetic Counseling Models of Service Delivery in Geographically Remote Settings

  • Eileen McDonald
  • Amanda Lamb
  • Barbara Grillo
  • Lee Lucas
  • Susan Miesfeldt
Original Research

Abstract

This work examined acceptability of cancer genetic counseling models of service delivery among Maine residents at risk for hereditary cancer susceptibility disorders. Pre-counseling, participants ranked characteristics reflecting models of care from most to least important including: mode-of-communication (in-person versus telegenetics), provider level of training (genetic specialty versus some training/experience), delivery format (one-on-one versus group counseling), and location (local versus tertiary service requiring travel). Associations between models of care characteristic rankings and patient characteristics, including rural residence, perceived cancer risk, and perceived risk for a hereditary cancer risk susceptibility disorder were examined. A total of 149/300 (49.7 % response rate) individuals from 11/16 Maine counties responded; 30.8 % were from rural counties; 92.2 % indicated that an important/the most important model of care characteristic is provider professional qualifications. Among other characteristics, 65.1 % ranked one-on-one counseling as important/the most important. In-person and local counseling were ranked the two least important characteristics (51.8 % and 52.1 % important/the most important, respectively). Responses did not vary by patient characteristics with the exception of greater acceptance of group counseling among those at perceived high personal cancer risk. Cancer telegenetic services hold promise for access to expert providers in a one-on-one format for rurally remote clients.

Keywords

Cancer genetic counseling Disparities Models of service delivery Telegenetics Rural 

References

  1. Bluman, L. G., Rimer, B. K., Berry, D. A., Borstelmann, N., Iglehart, J. D., Regan, K., & Winer, E. P. (1999). Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2. Journal of Clinical Oncology, 17(3), 1040–1046.PubMedGoogle Scholar
  2. Brierley, K. L., Campfield, D., Ducaine, W., Dohany, L., Donenberg, T., Shannon, K., & Matloff, E. T. (2010). Errors in delivery of cancer genetics services: implications for practice. Connecticut Medicine, 74(7), 413–423.PubMedGoogle Scholar
  3. Bureau of Economic Analysis, U.S. Department of Commerce. (2012). State Personal Income 2011 (released March 28, 2012). Retrieved July 16, 2012, 2012, from http://www.bea.gov/newsreleases/regional/spi/2012/spi0312.htm
  4. Calzone, K. A., Prindiville, S. A., Jourkiv, O., Jenkins, J., DeCarvalho, M., Wallerstedt, D. B., & Kirsch, I. R. (2005). Randomized comparison of group versus individual genetic education and counseling for familial breast and/or ovarian cancer. Journal of Clinical Oncology, 23(15), 3455–3464. doi:10.1200/JCO.2005.04.050.PubMedCrossRefGoogle Scholar
  5. Coelho, J. J., Arnold, A., Nayler, J., Tischkowitz, M., & MacKay, J. (2005). An assessment of the efficacy of cancer genetic counselling using real-time videoconferencing technology (telemedicine) compared to face-to-face consultations. European Journal of Cancer, 41(15), 2257–2261. doi:10.1016/j.ejca.2005.06.020.PubMedCrossRefGoogle Scholar
  6. Cohen, S. A., Gustafson, S. L., Marvin, M. L., Riley, B. D., Uhlmann, W. R., Liebers, S. B., & Rousseau, J. A. (2012). Report from the National Society of Genetic Counselors service delivery model task force: a proposal to define models, components, and modes of referral. Journal of Genetic Counseling, 21(5), 645–651. doi:10.1007/s10897-012-9505-y.PubMedCrossRefGoogle Scholar
  7. Committee on Evaluating Clinical Applications of Telemedicine, Institute of Medicine. (1996). A Guide to Assessing Telecommunications for Health Care. Washington: The National Academies Press.Google Scholar
  8. d’Agincourt--Canning, L., McGillivray, B., Panabaker, K., Scott, J., Pearn, A., Ridge, Y., & Portigal-Todd, C. (2008). Evaluation of genetic counseling for hereditary cancer by videoconference in British Columbia. BC Medical Journal, 50, 554–559. http://www.bcmj.org/article/evaluation-genetic-counseling-hereditary-cancer-videoconference-british-columbia.Google Scholar
  9. Elliott, A. M., Mhanni, A. A., Marles, S. L., Greenberg, C. R., Chudley, A. E., Nyhof, G. C., & Chodirker, B. N. (2012). Trends in telehealth versus on-site clinical genetics appointments in Manitoba: a comparative study. Journal of Genetic Counseling, 21(2), 337–344. doi:10.1007/s10897-011-9406-5.PubMedCrossRefGoogle Scholar
  10. Epplein, M., Koon, K. P., Ramsey, S. D., & Potter, J. D. (2005). Genetic services for familial cancer patients: a follow-up survey of National Cancer Institute Cancer Centers. Journal of Clinical Oncology, 23(21), 4713–4718.PubMedCrossRefGoogle Scholar
  11. Friedman, L., Cooper, H. P., Webb, J. A., Weinberg, A. D., & Plon, S. E. (2003). Primary care physicians’ attitudes and practices regarding cancer genetics: a comparison of 2001 with 1996 survey results. Journal of Cancer Education, 18(2), 91–94.PubMedCrossRefGoogle Scholar
  12. Garber, J. E., & Offit, K. (2005). Hereditary cancer predisposition syndromes. Journal of Clinical Oncology, 23(2), 276–292.PubMedCrossRefGoogle Scholar
  13. Garrett, C. C., Hocking, J., Chen, M. Y., Fairley, C. K., & Kirkman, M. (2011). Young people’s views on the potential use of telemedicine consultations for sexual health: results of a national survey. BMC Infectious Diseases, 11, 285. doi:10.1186/1471-2334-11-285.PubMedCentralPubMedCrossRefGoogle Scholar
  14. Greendale, K., & Pyeritz, R. E. (2001). Empowering primary care health professionals in medical genetics: how soon? How fast? How far? American Journal of Medical Genetics, 106(3), 223–232. doi:10.1002/ajmg.10010.PubMedCrossRefGoogle Scholar
  15. Guttmacher, A. E., Jenkins, J., & Uhlmann, W. R. (2001). Genomic medicine: who will practice it? A call to open arms. American Journal of Medical Genetics, 106(3), 216–222. doi:10.1002/ajmg.10008.PubMedCrossRefGoogle Scholar
  16. Hilgart, J. S., Hayward, J. A., Coles, B., & Iredale, R. (2012). Telegenetics: a systematic review of telemedicine in genetics services. Genetics in Medicine, 14(9), 765–776.CrossRefGoogle Scholar
  17. Hill, J. H., Burge, S., Haring, A., Young, R. A., Network, R. R., & Residency Research Network of Texas, Investigators. (2012). Communication technology access, use, and preferences among primary care patients: from the Residency Research Network of Texas (RRNeT). Journal of the American Board Family Medicine, 25(5), 625–634. doi:10.3122/jabfm.2012.05.120043.CrossRefGoogle Scholar
  18. Hughes, C., Gomez-Caminero, A., Benkendorf, J., Kerner, J., Isaacs, C., Barter, J., & Lerman, C. (1997). Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk. Patient Education and Counseling, 32(1–2), 51–62.PubMedCrossRefGoogle Scholar
  19. Lea, D. H., Johnson, J. L., Ellingwood, S., Allan, W., Patel, A., & Smith, R. (2005). Telegenetics in Maine: Successful clinical and educational service delivery model developed from a 3-year pilot project. Genetics in Medicine, 7(1), 21–27.PubMedCrossRefGoogle Scholar
  20. Lerman, C., Narod, S., Schulman, K., Hughes, C., Gomez-Caminero, A., Bonney, G., & Lynch, H. (1996). BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. The Journal of the American Medical Association, 275(24), 1885–1892.CrossRefGoogle Scholar
  21. Lerman, C., Biesecker, B., Benkendorf, J. L., Kerner, J., Gomez-Caminero, A., Hughes, C., & Reed, M. M. (1997). Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing. Journal of the National Cancer Institute, 89(2), 148–157.PubMedCrossRefGoogle Scholar
  22. Mair, F., Whitten, P., May, C., & Doolittle, G. C. (2000). Patients’ perceptions of a telemedicine specialty clinic. J Telemed Telecare, 6(1), 36–40.PubMedCrossRefGoogle Scholar
  23. Meropol, N. J., Daly, M. B., Vig, H. S., Manion, F. J., Manne, S. L., Mazar, C., & Zubarev, V. (2011). Delivery of Internet-based cancer genetic counselling services to patients’ homes: a feasibility study. Journal of Telemedicine and Telecare, 17(1), 36–40.PubMedCentralPubMedCrossRefGoogle Scholar
  24. Office of Management and Budget. (2005). List of Rural Counties and Designated Eligible Census Tracts in Metropolitan Counties. Retrieved August 9, 2012, 2012, from ftp://ftp.hrsa.gov/ruralhealth/eligibility2005.pdf
  25. United States Census Bureau. (2010). Census 2000 Summary File 1, Matrices H1 and H3. Retrieved August 9, 2012 Retrieved from http://factfinder2.census.gov/faces/tableservices/jsf/pages/productview.xhtml?src=bkmk.
  26. Vig, H. S., Armstrong, J., Egleston, B. L., Mazar, C., Toscano, M., Bradbury, A. R., & Meropol, N. J. (2009). Cancer genetic risk assessment and referral patterns in primary care. Genetic Testing and Molecular Biomarkers, 13(6), 735–741.PubMedCentralPubMedCrossRefGoogle Scholar
  27. Wideroff, L., Freedman, A. N., Olson, L., Klabunde, C. N., Davis, W., Srinath, K. P., & Ballard-Barbash, R. (2003). Physician use of genetic testing for cancer susceptibility: results of a national survey. Cancer Epidemiology, Biomarkers& Prevention, 12(4), 295–303.Google Scholar
  28. Zilliacus, E. M., Meiser, B., Lobb, E. A., Kelly, P. J., Barlow-Stewart, K., Kirk, J. A., & Tucker, K. M. (2011). Are videoconferenced consultations as effective as face-to-face consultations for hereditary breast and ovarian cancer genetic counseling? Genetics in Medicine, 13(11), 933–941. doi:10.1097/GIM.0b013e3182217a19.PubMedCrossRefGoogle Scholar

Copyright information

© National Society of Genetic Counselors, Inc. 2013

Authors and Affiliations

  • Eileen McDonald
    • 1
  • Amanda Lamb
    • 2
  • Barbara Grillo
    • 2
  • Lee Lucas
    • 3
  • Susan Miesfeldt
    • 2
    • 3
  1. 1.MaineHealthPortlandUSA
  2. 2.Maine Medical Center Cancer InstituteScarboroughUSA
  3. 3.Center for Outcomes Research and Evaluation, Maine Medical Center Research InstitutePortlandUSA

Personalised recommendations